We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Gastroenterology

Journal Scan / Research · December 01, 2020

Clinical Feasibility of a New Antireflux Ablation Therapy on Gastroesophageal Reflux Disease

Gastrointestinal Endoscopy

 

Additional Info

Gastrointestinal Endoscopy
Clinical Feasibility of a New Antireflux Ablation Therapy on Gastroesophageal Reflux Disease (With Video)
Gastrointest. Endosc. 2020 Dec 01;92(6)1190-1201, OV Hernández Mondragón, RA Zamarripa Mottú, LF García Contreras, RA Gutiérrez Aguilar, OM Solórzano Pineda, G Blanco Velasco, E Murcio Perez

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading